Virios Therapeutics Llc Stock Current Valuation
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Valuation analysis of Virios Therapeutics Llc helps investors to measure Virios Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Virios Therapeutics' price fluctuation is dangerous at this time. Calculation of the real value of Virios Therapeutics Llc is based on 3 months time horizon. Increasing Virios Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Virios Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Virios Stock. However, Virios Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.95 | Real 3.49 | Hype 3.97 | Naive 4.25 |
The intrinsic value of Virios Therapeutics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Virios Therapeutics' stock price.
Estimating the potential upside or downside of Virios Therapeutics Llc helps investors to forecast how Virios stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Virios Therapeutics more accurately as focusing exclusively on Virios Therapeutics' fundamentals will not take into account other important factors: Virios Therapeutics Llc Company Current Valuation Analysis
Virios Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Virios Therapeutics Current Valuation | 1.28 M |
Most of Virios Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virios Therapeutics Llc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Virios Therapeutics Llc has a Current Valuation of 1.28 M. This is 99.99% lower than that of the Biotechnology sector and 99.97% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Virios Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virios Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics of similar companies.Virios Therapeutics is currently under evaluation in current valuation category among its peers.
Virios Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 1.28 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 6.74 % | |||
| Shares Owned By Institutions | 3.60 % | |||
| Number Of Shares Shorted | 469.93 K | |||
| Price To Book | 1.37 X | |||
| EBITDA | 150.9 K | |||
| Net Income | (5.3 M) | |||
| Cash And Equivalents | 7.7 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 358.55 K | |||
| Current Ratio | 4.76 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (4.87 M) | |||
| Short Ratio | 0.64 X | |||
| Earnings Per Share | (5.75) X | |||
| Target Price | 3.0 | |||
| Beta | 1.58 | |||
| Market Capitalization | 172.1 K | |||
| Total Asset | 4.17 M | |||
| Retained Earnings | (61.47 M) | |||
| Working Capital | 3.81 M | |||
| Net Asset | 4.17 M |
About Virios Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virios Therapeutics Llc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics Llc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |